Townsend Tristan, Campbell Fiona, O'Toole Paul, Probert Chris
Department of Gastroenterology, Royal Liverpool University Hospital, Liverpool, UK.
Department of Pathology, Royal Liverpool University Hospital, Liverpool, UK.
Frontline Gastroenterol. 2019 Oct;10(4):388-393. doi: 10.1136/flgastro-2018-101040. Epub 2018 Nov 27.
Microscopic colitis (MC) is a common cause of chronic, non-bloody, watery diarrhoea in older patients. The diagnosis depends on characteristic histological findings. Bile acid malabsorption and autoimmune conditions, including coeliac disease, are more frequently found in patients with MC, but colorectal neoplasia and mortality are not increased. Non-steroidal anti-inflammatory drugs, proton-pump inhibitors, selective serotonin reuptake inhibitors and smoking tobacco confer an increased risk of developing MC. Although a so-called benign disease, which rarely causes serious complications, it does have an impact on the quality of life. Several treatment options exist, but budesonide is the only treatment proven in randomised-controlled trials to be effective and safe for induction and maintenance of remission. This article provides a practical overview for the gastroenterologist looking after patients with MC.
显微镜下结肠炎(MC)是老年患者慢性、非血性、水样腹泻的常见病因。诊断依赖于特征性的组织学表现。胆汁酸吸收不良和自身免疫性疾病,包括乳糜泻,在MC患者中更为常见,但结直肠肿瘤和死亡率并未增加。非甾体类抗炎药、质子泵抑制剂、选择性5-羟色胺再摄取抑制剂和吸烟会增加患MC的风险。尽管它是一种所谓的良性疾病,很少引起严重并发症,但确实会影响生活质量。有几种治疗选择,但布地奈德是唯一在随机对照试验中被证明对诱导和维持缓解有效且安全的治疗方法。本文为照顾MC患者的胃肠病学家提供了实用概述。